Leap Therapeutics, Inc.
LPTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$67,555 | -$81,414 | -$54,596 | -$40,587 |
| Dep. & Amort. | $5 | $15 | $16 | $29 |
| Deferred Tax | $0 | $0 | $0 | $379 |
| Stock-Based Comp. | $5,504 | $5,128 | $5,180 | $3,482 |
| Change in WC | $1,290 | $2,511 | -$651 | $1,013 |
| Other Non-Cash | $457 | $30,007 | $1,007 | $527 |
| Operating Cash Flow | -$60,299 | -$43,753 | -$49,044 | -$35,157 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $50,362 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$1,393 | $0 | $0 |
| Investing Cash Flow | $0 | $48,969 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $39,999 | $0 | $0 | $97,222 |
| Stock Repurch. | $0 | -$1 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2,815 | -$29 | -$210 | $813 |
| Financing Cash Flow | $37,184 | -$30 | -$210 | $98,035 |
| Forex Effect | -$279 | -$43 | -$162 | -$33 |
| Net Chg. in Cash | -$23,394 | $5,143 | -$49,416 | $62,845 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $70,643 | $65,500 | $114,916 | $52,071 |
| End Cash | $47,249 | $70,643 | $65,500 | $114,916 |
| Free Cash Flow | -$60,299 | -$43,753 | -$49,044 | -$35,157 |